Former Minister of Economy, Trade and Industry Yasutoshi Nishimura visited Toregem BioPharma booth at the "Global Startup Expo 2026"NEW!!
Toregem BioPharma participated in ”Global Startup Expo 2026,” held from October 5 to 7, 2026. The event brought together key stakeholders from the global deep-tech ecosystem, focusing on the 17 strategic sectors identified by Japan’s Growth Strategy Headquarters, including six priority areas designated by the Japanese Government.On October 6th, we had the honor to welcome […]
We are going to exhibit at BioJapan 2026, which will be held from October 7th to 9th, 2026.
We are pleased to announce that we will have a booth at BioJapan 2026, one of Asia's largest partnering events in the bio science field.(Booth number: A-08)This event will be held at Pacifico Yokohama from October 7(Wed.) to 9 (Fri.). For more information, please visithttps://jcd-expo.jp/en/
Selected for the "Global Startup Support - Expand Stage-" of the international hub for future medicine, "Nakanoshima Qross."
Toregem BioPharma Co., Ltd, will expand the business development with support of "Nakanoshima Qross," such as assistance in participating in major life science events in the world and facilitating local business partnering.
Announcement regarding theNew Exective Leadership Structure.
Toregem BioPharma Co., Ltd. Announced new executive leadership structure designed to support future business expansion and further enhance corporate value.As the Company enters the commercialization and expansion phase,Toregem would adopt a leadership structure that clearly delineates functional expertise and responsibilities, enabling rapid and consistent decision-making. Press release
Announcement for Completion of the PMDA Investigation of CTN (Clinical Trial Notification)for TRG035 Phase IIa Trial.
Toregem BioPharma Co., Ltd has submitted CTN to PMDA (Pharmaceuticals and Medical Devices Agency) regarding an exploratory clinical trial of an antibody drug (TRG035) for congenital tooth agenesis, and we are pleased to announce that the PMDA has completed the required investigation today 17-Aug-26. Press release